Skip to content

Age of Red Blood Cells in Premature Infants Study (ARIPI)

Age of Red Blood Cells in Premature Infants Study (ARIPI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00326924
Enrollment
377
Registered
2006-05-17
Start date
2006-05-31
Completion date
2012-06-30
Last updated
2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth

Keywords

Transfusion

Brief summary

To determine if the age of blood transfused to new borns in the NICU setting has an impact on their outcome.

Interventions

BIOLOGICALTransfusion

PRBC blood transfusions.

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Minutes to 37 Weeks
Healthy volunteers
No

Inclusion criteria

* birthweight of less than 1250g * admitted to participating NICU * consent acquired from proxy for the patient

Exclusion criteria

* already received one or more transfusions * requirement for an exchange transfusion * will be receiving directed donations * have rare blood types/difficult cross-match * proxy has refused consent * moribund on admission to NICU/expected to die * mitigating child protection issues

Design outcomes

Primary

MeasureTime frameDescription
1. Composite Outcome of Necrotizing Enterocolitis, Intraventricular Hemorrhage, Bronchopulmonary Dysplasia and Retinopathy of Prematurity at 30 and 90-days. 2. Mortality2 weeks, 4 weeks, 12 weeks, 90 daysThe primary outcome was a composite outcome composed of mortality and major neonatal morbidities associated with acute organ dysfunction or failure. In addition to death, the 4 major morbidities comprising the composite outcome were bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and intraventricular hemorrhage.

Secondary

MeasureTime frameDescription
Clinically Suspected Infection and Culturally Confirmed Infections90 daysInfection was categorized as clinically suspected and positive cultures.
Length of Stayuntil last participants left neonatal intensive care unitLength of Stay in neonatal intensive unit
Number of Participants Using Mechanical Ventilation.whether a mechanical ventilation was used at any time point during 90 daysNumber of Participants using Mechanical Ventilation

Countries

Canada

Participant flow

Participants by arm

ArmCount
Biological
PRBCs that are less than 7 days old are considered 'fresh'. Transfusion: PRBC blood transfusions.
188
Standard PRBCs
PRBCs 'stored' as per hospital policy. Transfusion: PRBC blood transfusions.
189
Total377

Baseline characteristics

CharacteristicBiologicalStandard PRBCsTotal
Age, Continuous10.0 days
STANDARD_DEVIATION 9.7
9.9 days
STANDARD_DEVIATION 9.5
10 days
STANDARD_DEVIATION 9.6
Race/Ethnicity, Customized
Mothers' characteristics
Aboriginal
10 Participants20 Participants30 Participants
Race/Ethnicity, Customized
Mothers' characteristics
Arab
3 Participants1 Participants4 Participants
Race/Ethnicity, Customized
Mothers' characteristics
Asian
6 Participants8 Participants14 Participants
Race/Ethnicity, Customized
Mothers' characteristics
Black
17 Participants24 Participants41 Participants
Race/Ethnicity, Customized
Mothers' characteristics
Filipino
0 Participants4 Participants4 Participants
Race/Ethnicity, Customized
Mothers' characteristics
Latin American
4 Participants1 Participants5 Participants
Race/Ethnicity, Customized
Mothers' characteristics
Other or unknown
10 Participants8 Participants18 Participants
Race/Ethnicity, Customized
Mothers' characteristics
White
138 Participants123 Participants261 Participants
Region of Enrollment
Canada
188 participants189 participants377 participants
Sex: Female, Male
Female
79 Participants95 Participants174 Participants
Sex: Female, Male
Male
109 Participants94 Participants203 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1880 / 189
serious
Total, serious adverse events
0 / 1881 / 189

Outcome results

Primary

1. Composite Outcome of Necrotizing Enterocolitis, Intraventricular Hemorrhage, Bronchopulmonary Dysplasia and Retinopathy of Prematurity at 30 and 90-days. 2. Mortality

The primary outcome was a composite outcome composed of mortality and major neonatal morbidities associated with acute organ dysfunction or failure. In addition to death, the 4 major morbidities comprising the composite outcome were bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and intraventricular hemorrhage.

Time frame: 2 weeks, 4 weeks, 12 weeks, 90 days

ArmMeasureValue (NUMBER)
Biological1. Composite Outcome of Necrotizing Enterocolitis, Intraventricular Hemorrhage, Bronchopulmonary Dysplasia and Retinopathy of Prematurity at 30 and 90-days. 2. Mortality99 participants
Standard PRBCs1. Composite Outcome of Necrotizing Enterocolitis, Intraventricular Hemorrhage, Bronchopulmonary Dysplasia and Retinopathy of Prematurity at 30 and 90-days. 2. Mortality100 participants
Secondary

Clinically Suspected Infection and Culturally Confirmed Infections

Infection was categorized as clinically suspected and positive cultures.

Time frame: 90 days

ArmMeasureValue (NUMBER)
BiologicalClinically Suspected Infection and Culturally Confirmed Infections146 number of participants
Standard PRBCsClinically Suspected Infection and Culturally Confirmed Infections146 number of participants
Secondary

Length of Stay

Length of Stay in neonatal intensive unit

Time frame: until last participants left neonatal intensive care unit

ArmMeasureValue (MEAN)
BiologicalLength of Stay84 number of days
Standard PRBCsLength of Stay77 number of days
Secondary

Number of Participants Using Mechanical Ventilation.

Number of Participants using Mechanical Ventilation

Time frame: whether a mechanical ventilation was used at any time point during 90 days

ArmMeasureValue (NUMBER)
BiologicalNumber of Participants Using Mechanical Ventilation.151 participants
Standard PRBCsNumber of Participants Using Mechanical Ventilation.153 participants

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026